Editor’s note: The Muscular Dystrophy News Today team is providing in-depth coverage of the 2021 MDA Virtual Clinical and Scientific Conference, March 15–18. Go here to read the latest stories from the conference. Treatment with Amondys 45 was safe and well-tolerated, showing little to no evidence of accumulation in the blood…
MDA 2021
Editor’s note: The Muscular Dystrophy News Today team is providing in-depth coverage of the 2021 MDA Virtual Clinical and Scientific Conference, March 15–18. Go here to read the latest stories from the conference. Switching from prednisone to Emflaza (deflazacort) successfully met efficacy and tolerability goals in most patients with Duchenne…
Next week’s 2021 MDA Virtual Clinical and Scientific Conference is expected to attract more than 1,200 clinicians and researchers from across the U.S. with expertise in neuromuscular conditions. Hosted by the Muscular Dystrophy Association (MDA), the conference runs March 15 to…
Recent Posts
- MDA 2026: Early trial of PGN-EDODM1 shows biomarker activity in DM1
- As my FSHD progression worsens, I’m battling feelings of shame
- MDA 2026: Sevasemten halts functional decline in Becker trial
- MDA 2026: Keynote speaker to MDA community: ‘Your voice is powerful’
- Guest Voice: Navigating the windy road of rare disease specialists